Decibel Therapeutics Inc (DBTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: DBTX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2022-01-04	2022-01-03	PS Planned sale	Trask Anna See Remarks Officer	377 -16.8% 5.03 1,896 USD	377 -16.8%	5.03	1,896 USD
2022-01-04	2022-01-03	PS Planned sale	Trask Anna See Remarks Officer	1 -0.0% 5.04 5 USD	1 -0.0%	5.04	5 USD
2021-12-06	2021-12-02	PS Planned sale	Trask Anna See Remarks Officer	378 -14.4% 6.34 2,395 USD	378 -14.4%	6.34	2,395 USD
2021-12-06	2021-12-02	PS Planned sale	Trask Anna See Remarks Officer	4,913 -65.2% 6.37 31,293 USD	4,913 -65.2%	6.37	31,293 USD
2021-11-04	2021-11-03	PS Planned sale	Trask Anna See Remarks Officer	378 -4.8% 8.34 3,152 USD	378 -4.8%	8.34	3,152 USD
2021-11-03	2021-11-02	PS Planned sale	Trask Anna SEE REMARKS Officer	4,913 -38.3% 8.31 40,827 USD	4,913 -38.3%	8.31	40,827 USD
2021-10-15	2021-10-14	PS Planned sale	Trask Anna See Remarks Officer	5,364 -29.5% 7.55 40,481 USD	5,364 -29.5%	7.55	40,481 USD
2021-09-17	2021-09-15	B Purchase	Reid Laurence President and Chief Executive Executive Director	10,000 +63.1% 7.64 76,400 USD	10,000 +63.1%	7.64	76,400 USD
2021-02-19	2021-02-17	B Purchase	Foy Matthew Non-Executive Director Large shareholder	150,000 +14.5% 18.00 2,700,000 USD	150,000 +14.5%	18.00	2,700,000 USD
2021-02-19	2021-02-17	B Purchase	GLAXOSMITHKLINE PLC Non-Executive Director	150,000 +14.5% 18.00 2,700,000 USD	150,000 +14.5%	18.00	2,700,000 USD
2021-02-19	2021-02-17	B Purchase	Thompson Peter A. Non-Executive Director Large shareholder	555,566 +169.5% 18.00 10,000,188 USD	555,566 +169.5%	18.00	10,000,188 USD
2021-02-19	2021-02-17	B Purchase	Thompson Peter A. Non-Executive Director Large shareholder	1,111,100 +40.7% 18.00 19,999,800 USD	1,111,100 +40.7%	18.00	19,999,800 USD
2021-02-19	2021-02-17	B Purchase	Casdin Partners Master Fund, L.P. Large shareholder	575,000 +105.2% 18.00 10,350,000 USD	575,000 +105.2%	18.00	10,350,000 USD
2021-02-19	2021-02-17	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	555,566 +169.5% 18.00 10,000,188 USD	555,566 +169.5%	18.00	10,000,188 USD
2021-02-19	2021-02-17	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	1,111,100 +40.7% 18.00 19,999,800 USD	1,111,100 +40.7%	18.00	19,999,800 USD